To: clochard who wrote (2549 ) 2/26/1998 12:46:00 PM From: Linda Kaplan Respond to
FORTUNE article, March 16, 1998 issue (yeah, I know it's not March 16th yet, but you'll have to take that up with FORTUNE). Authors David Stipp and Robert Whitaker. Entitled "Sex Medicine. The Selling of Impotence," this article starts on page 115.The company also said that its Mexican trial had yielded statistically significant results. Of 148 men, 62% using Vasomax achieved orgasm during intercourse, vs. 42% who had taken a placebo. The company said it planned to seek marketing approval in Mexico during the first few months of 1997 and that by summer it would be knocking on the FDA's door.... Last May the company announced that 40% of men had responded positively to Vasomax, vs. 17% on placebo. Up went the stock price again. Zonagen was beginning to seem unstoppable--unless you were paying close attention. The results in its second US trials were less than rosy (some 34% responded positively, compared with 21% on placebo), but that didn't dent investors' fervor... ...Before they began, its investigators administered doses of Vasomax to patients and disqualified anyone who showed significant adverse effects. According to Fergusen, no fewer than 44 of more than 500 volunteers were eliminated at the outset of the largest trial. The "adverse events" they experienced included a racing heart, dizziness and low blood pressure.
